Literature DB >> 11413411

Late-onset form of lattice corneal dystrophy caused by leu527Arg mutation of the TGFBI gene.

K Hirano1, Y Hotta, M Nakamura, K Fujiki, A Kanai, N Yamamoto.   

Abstract

PURPOSE: To report two Japanese patients who were clinically diagnosed with late-onset and sporadic lattice corneal dystrophy (LCD) in whom a Leu527Arg mutation in the TGFBI gene was found.
METHODS: Molecular genetic analysis was performed on DNA extracted from peripheral leukocytes from the patients. Exons 4, 11, and 12 of the TGFBI gene were amplified by polymerase chain reaction and directly sequenced. Histopathologic study was performed on the corneal tissue obtained during deep lamellar keratoplasty (DLK) from one of the patients.
RESULTS: Patient 1 was a 74-year-old man who noticed a visual disturbance at the age of 72 years. Deep stromal opacities with nodular deposits and thick lattice lines were observed only in the right cornea, and DLK was performed. Patient 2 was an 82-year-old man who had LCD (similar in appearance to that in patient 1) in both eyes without visual disturbance. Neither of the patients had a family history of corneal problems and had no episode of corneal erosion. A heterozygous single base-pair transition (CTG to CGG, leucine to arginin) was detected in codon 527 of the TGFBI gene in both patients. No mutation was found in codons 124, 501, 518, 546, or 555. Histopathologically, relatively large amyloid deposits in the deep corneal stroma and ribbons of amyloid deposits just beneath the Bowman's layer were observed in the corneal tissue of patient 1.
CONCLUSIONS: Clinical features and pathologic findings of the late-onset form of LCD with an L527R mutation in the TGFBI gene were made clear.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413411     DOI: 10.1097/00003226-200107000-00017

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Homozygous mutation (L527R) of TGFBI in an individual with lattice corneal dystrophy.

Authors:  N Yamada; T-I Chikama; N Morishige; R Yanai; T Nishida; M Inui; K Seki
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  Lattice corneal dystrophy type III in patients with a homozygous L527R mutation in the TGFBI gene.

Authors:  Tomoyo Funayama; Yukihiko Mashima; Motoko Kawashima; Masakazu Yamada
Journal:  Jpn J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.447

3.  Development of a DNA chip for the diagnosis of the most common corneal dystrophies caused by mutations in the betaigh3 gene.

Authors:  So Young Yoo; Tae-Im Kim; Sang Yup Lee; Eung Kweon Kim; Ki Chang Keum; Nae Choon Yoo; Won Min Yoo
Journal:  Br J Ophthalmol       Date:  2007-01-10       Impact factor: 4.638

4.  Rapid genotyping for most common TGFBI mutations with real-time polymerase chain reaction.

Authors:  Shigeo Yoshida; Yoko Yamaji; Ayako Yoshida; Yoshihiro Noda; Yuji Kumano; Tatsuro Ishibashi
Journal:  Hum Genet       Date:  2005-03-03       Impact factor: 4.132

5.  Surgical outcome after phototherapeutic keratectomy in patients with TGFBI-linked corneal dystrophies in relation to molecular genetic findings.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-06       Impact factor: 3.117

Review 6.  The IC3D classification of the corneal dystrophies.

Authors:  Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

7.  An R124C mutation in TGFBI caused lattice corneal dystrophy type I with a variable phenotype in three Chinese families.

Authors:  Zhe Liu; Yi-qiang Wang; Qing-hua Gong; Li-xin Xie
Journal:  Mol Vis       Date:  2008-06-30       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.